Regeneron Pharmaceuticals, Inc.
REGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,488,200 | $2,730,000 | $3,105,900 | $2,885,600 |
| Short-Term Investments | $6,524,300 | $8,114,800 | $4,636,400 | $2,809,100 |
| Receivables | $6,211,900 | $5,667,300 | $5,328,700 | $6,036,500 |
| Inventory | $3,087,300 | $2,580,500 | $2,401,900 | $1,951,300 |
| Other Curr. Assets | $349,200 | $386,600 | $411,200 | $332,400 |
| Total Curr. Assets | $18,660,900 | $19,479,200 | $15,884,100 | $14,014,900 |
| Property Plant & Equip (Net) | $4,599,700 | $4,146,400 | $3,763,000 | $3,482,200 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,148,600 | $1,038,600 | $915,500 | $6,700 |
| Long-Term Investments | $8,900,100 | $5,396,500 | $6,591,800 | $6,838,000 |
| Tax Assets | $3,314,100 | $2,575,400 | $1,723,700 | $876,900 |
| Other NC Assets | $1,136,000 | $444,100 | $336,400 | $216,100 |
| Total NC Assets | $19,098,500 | $13,601,000 | $13,330,400 | $11,419,900 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $37,759,400 | $33,080,200 | $29,214,500 | $25,434,800 |
| Liabilities | – | – | – | – |
| Payables | $789,500 | $606,600 | $589,200 | $564,000 |
| Short-Term Debt | $0 | $0 | $0 | $719,700 |
| Tax Payable | $213,200 | $0 | $300 | $326,300 |
| Deferred Revenue | $627,700 | $458,900 | $477,900 | $442,000 |
| Other Curr. Liab. | $2,313,900 | $2,357,900 | $2,073,900 | $1,880,500 |
| Total Curr. Liab. | $3,944,300 | $3,423,400 | $3,141,300 | $3,932,500 |
| LT Debt | $2,704,400 | $2,702,900 | $2,701,400 | $1,980,000 |
| Deferred Rev, NC | $185,700 | $126,700 | $69,800 | $73,300 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1,571,400 | $854,100 | $638,000 | $680,200 |
| Total NC Liab. | $4,461,500 | $3,683,700 | $3,409,200 | $2,733,500 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $720,000 | $720,000 | $720,000 | $719,700 |
| Total Liabilities | $8,405,800 | $7,107,100 | $6,550,500 | $6,666,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $100 | $100 | $100 | $100 |
| Retained Earnings | $31,672,900 | $27,260,300 | $23,306,700 | $18,968,300 |
| AOCI | -$7,900 | -$80,900 | -$238,800 | -$26,200 |
| Other Equity | -$2,311,500 | -$1,206,400 | -$404,000 | -$173,400 |
| Total Equity | $29,353,600 | $25,973,100 | $22,664,000 | $18,768,800 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $37,759,400 | $33,080,200 | $29,214,500 | $25,434,800 |
| Net Debt | $216,200 | -$27,100 | -$404,500 | -$185,900 |